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1. Introduction 
In the past years we have been studying the pep- 
tidy1 transferase centre of the larger ribosomal subunit 
[l-3 review] . This centre is responsible for the cata- 
lysis of peptide bond formation in protein synthesis. 
The peptidyl transfer reaction presumably takes place 
in several steps, amongst which are the binding of the 
peptidyl donor and acceptor substrates at the P- and 
the A-site on the peptidyl transfer centre. There is 
ample evidence that only the terminal moieties of 
tRNA interact with the centre, and we have been 
developing a system to resolve the binding steps using 
simple substrates containing the CpCpA oligonucleo- 
tides of tRNA. We have already reported a system for 
study of substrate-interaction at the P-site of the 
peptidyl transferase centre, based on the measurement 
of CACCA-Leu-Ac binding to 50 S ribosomal sub- 
units in the presence of ethanol. Using this system, 
substrate-binding at the P-site was shown to be in- 
hibited by a number of antibiotic inhibitors of pep- 
tidy1 transfer but unaffected or even stimulated by 
others [4,5]. The present work deals with a comple- 
mentary assay for substrate-binding at the A-site. The 
assay is similar to that for substrate-binding at the 
P-site but uses UACCA-Leu (or CACCA-Leu) in- 
stead of CACCA-Leu-Ac. The present results, to- 
gether with those of another study [6,7], suggest 
that certain antibiotic inhibitors of peptidyl transfer 
act on both the A- and the P-site of the peptidyl 
transferase centre, others act only on one of the sites, 
and yet others act at neither site. A preliminary report 
of this work has already been published [8]. 
North-Holland Publishing Company -- Amsterdam 
2. Materials and methods 
2.1. Materials 
Ribosomes and ribosomal subunits were prepared 
from log phase E. coli MRE 600 by the method of 
Staehelin [lo] . Cross contamination of ribosome 
subunits was less than 5%. Sources of antibiotics were 
as previously indicated [ 11,5] . CACCA-3H-Leu was 
prepared essentially as described elsewhere [9]. 
2.2. Assay of UACCA-3H-Leu binding 
The standard incubation mixture contained (unless 
otherwise indicated) UACCA-3H-Leu (c l-2 nM; 
specific activity c 20 Ci/mmole), 3-5 mg/ml 50 S 
ribosomal subunits, 13 mM Mg acetate, 270 mM KCl, 
33 mM tris-HCl (pH 7.4) and 50% (v/v) ethanol. 150 
~1 aliquots were incubated at 0’ for 5-20 min and 
then centrifuged at 35,000 g for 5 min at 4”. 100 ~1 
of the supernatant was mixed with 3 ml scintillation 
fluid (Bray’s solution [ 121 with 4% CAB-0-Sil) and 
radioactivity estimated in a scintillation spectrometer. 
Parallel incubations without ribosomes were included 
for estimation of total radioactivity under identical 
quenching conditions. The amount of bound substrate 
was calculated by difference. 
3. Results 
3.1. UACCA-Leu binding to ribosomes and their 
subunits 
In the experiments shown in table 1, up to 69%, 
40% and 10% of the added UACCA-Leu was bound 
to 70 S ribosomes, 50 S subunits and 30 S subunits, 
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Table 1 
Binding of UACCA-Leu to ribosomes and their subunits: ef- 
fect of chloramphenicol. 
-____ 
Percentage of added UACCA-Leu bound 
Ribosomes 
or subunits 
No antibiotic 
Plus 1 mM 
chloramphenicol 
Difference 
Exp. 1 
70 s 
50 s 
30 s 
69 12 57 
33 6 27 
10 13 -3 
Exp. 2 
50 s 40 0 40 
3 mg/ml ribosomes or subunits were used. Time of incubation 
was 20 min. Other conditions and method of assay were as in 
text (2.3). 
respectively, in presence of 50% (v/v) ethanol. The 
extent of binding varied with different ribosome pre- 
parations. Addition of 1 mM chloramphenicol lowered 
the binding to O-12% with 70 S ribosomes or 50 S 
subunits but had no effect on binding with 30 S sub- 
units. We conclude that the majority of the 
UACCA-Leu binding to 70 S ribosomes and 50 S 
subunits took place at a chloramphenicol-sensitive 
site. The remainder of the binding to these particles, 
as well as the binding to 30 S subunits, was presum- 
ably due to interaction at other sites. Since chloram- 
phenicol acts on the peptidyl transferase centre [ 1, 3 
review], it is reasonable to suppose that the chloram- 
phenicol-sensitive binding represents interaction of 
Table 2 
Binding of UACCA-Leu to ribosomes and their subunits; 
effect of ethanol concentration. 
Ribosomes 
or subunits 
Percentage of added UACCA-Leu bound 
33% (v/v) ethanol 50% (v/v) ethanol 
70 s 44 51 
50 s 16 27 
3 mg/ml70 S ribosomes or 50 S subunits were used. Time of 
incubation was 20 min. Other conditions and method of assay 
were as in text. Figures for percentage binding have been cor- 
rected for nonspecific binding by subtraction of estimates 
obtained in parallel incubations with 1 mM chloramphenicol 
(for explanation see text). 
UACCA-Leu at a site on the peptidyl transferase 
centre. 
There is no detectable binding of UACCA-Leu to 
50 S subunits under normal ionic conditions in ab- 
sence of alcohol. Table 2 shows that in presence of 
33% ethanol (as used in the ‘fragment reaction’ for 
assay of the peptidyl transfer reaction [l] there is a 
weak but significant binding of UACCA-Leu to 50 S 
subunits at a chloramphenicol-sensitive site. Binding 
is more effective at 50% ethanol. 70 S ribosomes are 
more than twice as active as 50 S subunits in binding 
UACCA-Leu, both at 33% and 50% ethanol. The 
concentration of alcohol used in our standard assay 
is 50% (v/v). 
3.2, Characteristics of the complex 
The interaction between UACCA-Leu and 50 S 
subunits takes place rapidly, equilibrium being at- 
tained in less than 5 min at 0”. In contrast, binding 
of UACCA-Leu to 70 S ribosomes is relatively slow, 
and completion requires 20-60 min (fig. 1). With 
both 50 S subunits and 70 S ribosomes, the complex 
can be completely dissociated by resuspension of the 
ribosomes in buffer without ethanol. The binding is 
also reversed by chloramphenicol. 
In order to characterize the products, UACCA-3H- 
Leu was bound to 50 S subunits in the standard 
system. The complex was then isolated and dissociated 
by resuspension in buffer without ethanol, and the 
eluate characterized by paper ionphoresis at pH 6.5. 
About 90% of the radioactivity migrated as a single 
band at the same rate as a UACCA-Leu marker. The 
possibility remained that condensation takes place 
during the binding process with the formation of 
UACCA-(Leu)2, which would migrate at about the 
same rate as UACCA-Leu. Such a possibility was 
eliminated by subjection of similar eluates to alkaline 
hydrolysis followed by chromatography on paper, 
using a butanol/acetic acid solvent. The product 
migrated at the same rate as Leu, and less than 10% 
of the radioactivity was coincident with a Leu-Leu 
marker. We conclude that the complex consists 
primarily of UACCA-Leu, bound loosely by non- 
covalent bonds to a chloramphenicol-sensitive site 
presumably on the peptidyl transferase centre. 
3.3. Effects of antibiotics 
Table 3 shows effects of a number of peptidyl 
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Fig. 1. Binding of UACCA-Leu to (A) 70 S ribosomes or (B) 50 S ribosomal subunits. 3 mg/ml of 70 S ribosomes or 50 S sub- 
units were used and samples of incubation mixtures were taken at the indicated times. Other experimental conditions were as in 
Materials and methods. l : Binding of UACCA-Leu in the control; o: binding of UACCA-Leu in the presence of chloramphenicol. 
transferase inhibitors on the binding of UACCA-Leu 
to 50 S subunits. For comparison, effects of the same 
inhibitors on the binding of CACCA-Leu-Ac to 50 S 
subunits are reproduced from a previous publication 
[5] . Chloramphenicol strongly inhibited binding of 
the Leu substrate but stimulated binding of the 
Ac-Leu substrate. Lincomycin strongly inhibited 
binding of the Leu substrate and considerably less 
effectively inhibited binding of the Ac-Leu substrate. 
Streptogramin A, carbomycin and spiramycin III in- 
hibited binding of both substrates. Oleandomycin 
weakly inhibited binding of the Leu substrate but 
weakly stimulated binding of the Ac-Leu substrate. 
Erythromycin, celesticetin and viridogrisein weakly 
stimulated the binding of both substrates. Other 
assays show that the binding of CACCA-Leu re- 
sponds of these antibiotics in the same way as that of 
UACCA-Leu. The concentrations of antibiotics em- 
ployed in these assays were sufficient to give nearly 
complete inhibition of the fragment reaction (except 
Table 3 
Binding of UACCA-Leu to 50 S ribosomal subunits: effects of antibiotics. 
Antibiotic 
Concn. 
(mM) 
Binding of: 
UACCA-Leu *CACCA-Leu-AC 
(% of control) (% of control) 
Chloramphenicol 1 0 
Lincomycin 1 4 
Streptogramin A 0.1 11 
Carbomycin 1 10 
Spiramycin III 1 24 
Neospiramycin III 1 54 
Oleandomycin 1 64 
Erythromycin 1 106 
Celesticetin 1 120 
Viridogrisein 1 120 
126 
36 
8 
12 
12 
125 
156 
123 
160 
Assays were carried out as indicated in the text. Edeine (2 PM), polydextran sulphate (5 PM), tetracycline (0.1 mM), anisomycin 
(0.1 mM) and siomycin (0.1 mM) were without significant effect. 
* Data reproduced from ref. 5. 
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in the cases of erythromycin and oleandomycin) 
[13]. Similar effects of the antibiotics were observed 
using 70 S ribosome preparations. However, in this 
case celesticetin and viridogrisein had no significant 
effect on binding of UACCA-Leu at early times of 
incubation (at 50% ethanol). 
4. Discussion 
The existence of specific binding sites on the pep- 
tidy1 transferase centre for the peptidyl donor and 
acceptor substrates is suggested not only by a priori 
considerations but also on experimental grounds. 
Thus, studies on the peptidyl transfer reaction with 
model compounds show that there is specificity to- 
wards the terminal C and A of the tRNA in aminoacyl- 
tRNA [ 14, 151 as well as a requirement for the correct 
linkage between the aminoacyl group and the A [ 161. 
Studies on the fragment reaction show that for pep- 
tidy1 donor substrates to be active there must be at 
least three nucleotides present, but that the presence 
of additional nucleotides does not affect activity [9]. 
The simplest explanation for such requirements is that 
there are specific binding sites for the termini of the 
peptidyl donor and acceptor substrates on the pep- 
tidy1 transferase centre. Further evidence for a specific 
binding site in the case of the peptidyl donor substrate 
is provided by the demonstration that there is just 
one site available per 50 S subunit for binding of 
CACCA-Leu-Ac [I]. 
It is reasonable to suppose that CACCA-Leu-Ac 
would tend to bind at the P-site, while UACCA-Leu 
would tend to bind at the A-site. Thus, the former 
but not the latter is a good peptidyl donor substrate 
[9] , while the latter but not the former is a peptidyl 
acceptor substrate. Our observations on the differential 
responses to antibiotics of the binding of these two 
substrates give us confidence that they do, in fact, 
bind at distinct sites in our assay systems, and that 
the two types of binding reflect interaction at the 
P-site and the A-site. 
An assay for the study of fragment binding to 
ribosomes at the A-site has also been developed by 
Pestka [6,7]. He reports that the binding of CACCA- 
Phe can occur in absence of alcohol if 70 S ribosomes 
(but not 50 S subunits) are employed. The system 
thus has the advantage over ours that it avoids the use 
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of alcohol. On the other band, the requirement for 
70 S ribosomes, which has yet to be explained, lowers 
the resolution of the assay since binding might be 
affected not only by factors which directly influence 
the peptidyl transferase centre but also by factors 
which influence the interaction between 50 S and 30 S 
subunits. Moreover, the binding to 70 S ribosomes takes 
place slowly (and is relatively stable), in contrast to 
the binding to 50 S subunits (in presence of alcohol) 
which is rapid (and relatively weak) as is to be expec- 
ted for a simple reversible binding reaction. It thus 
appears that the binding to 70 S ribosomes involves 
some secondary reaction, such as a conformational 
change of the ribosome. Although the present system 
and that of Pestka are both subject to limitations, 
the limitations are of different kinds, and the systems 
are thus complementary to one another. The re- 
sponses of Pestka’s system to antibiotics [7] are very 
similar to those reported here (for UACCA-Leu) 
and thus give confidence that the systems are not 
artefactual. 
Inhibition of fragment-binding by an antibiotic 
does not necessarily imply that substrate and anti- 
biotic compete directly for binding at overlapping 
sites. The substrate and antibiotic binding sites might 
be spatially-separated but allosterically-linked. We are 
inclined to think that the allostery model is closer to 
reality in cases where inhibition is only partial, such 
as the action of lincomycin on the P-site and of spir- 
amycin III on the A-site. The allosteric model could 
also hold in cases of nearly complete inhibition. Thus, 
studies with puromycin suggest hat lincomycin and 
chloramphenicol do not bind directly at the A-site 
[ 171 even though they effectively inhibit UACCA- 
Leu binding (table 3) and CACCA-Phe binding [7]. 
The failure of celesticetin to inhibit binding of either 
substrate is of particular interest, in view of the in- 
hibitory action of celesticetin on the fragment reac- 
tion and the close relation of its structure to that of 
lincomycin (which is a good inhibitor of fragment 
binding). Celesticetin must clearly inhibit the peptidyl 
transfer reaction by some mechanism other than 
blockage of substrate binding. 
Regardless of which models of antibiotic action 
are correct, there can be little doubt that the peptidyl 
transferase inhibitors in table 3 have a variety of 
effects on substrate-binding, including inhibition of 
substrate-binding at both, one, or neither site, and 
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stimulation of substrate-binding. Such a variety of 
effects is intriguing in view of the knowledge that 
these peptidyl transferase inhibitors all bind to the 
50 S subunit at mutually exclusive sites [3 : review; 
8,171. 
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